| 1. |
Keratosis
|
|
|
2 genes: KEAP1 | NFE2L2
|
14.82 |
1 |
| 2. |
Prostatic Neoplasms
|
|
|
3 genes: KEAP1 | NFE2L2 | NR3C1
|
13.36 |
4 |
| 3. |
Carcinoma, Non-Small-Cell Lung
|
|
|
2 genes: KEAP1 | NFE2L2
|
10.22 |
2 |
| 4. |
Gastrointestinal Diseases
|
|
|
2 genes: KEAP1 | NFE2L2
|
9.87 |
1 |
| 5. |
46, XX Disorders of Sex Development
|
|
|
1 gene: NR3C1
|
7.17 |
1 |
| 6. |
Gallbladder Neoplasms
|
|
|
1 gene: KEAP1
|
5.91 |
1 |
| 7. |
Primary Ovarian Insufficiency
|
|
|
1 gene: NFE2L2
|
5.73 |
1 |
| 8. |
Lung Diseases, Obstructive
|
|
|
1 gene: NR3C1
|
5.49 |
1 |
| 9. |
Vascular System Injuries
|
|
|
1 gene: NFE2L2
|
5.37 |
1 |
| 10. |
Carcinoma, Pancreatic Ductal
|
|
|
1 gene: NFE2L2
|
5.29 |
1 |
| 11. |
Emphysema
|
|
|
1 gene: NFE2L2
|
5.17 |
1 |
| 12. |
Ocular Hypertension
|
|
|
1 gene: NR3C1
|
5.11 |
1 |
| 13. |
Disease Progression
|
|
|
1 gene: KEAP1
|
4.91 |
1 |
| 14. |
Encephalomyelitis, Autoimmune, Experimental
|
|
|
1 gene: NFE2L2
|
4.90 |
1 |
| 15. |
Carcinoma, Renal Cell
|
|
|
1 gene: KEAP1
|
4.86 |
1 |
| 16. |
Hepatitis
|
|
|
1 gene: KEAP1
|
4.76 |
1 |
| 17. |
Psychotic Disorders
|
|
|
1 gene: NR3C1
|
4.72 |
1 |
| 18. |
Chromosome Breakage
|
|
|
1 gene: NFE2L2
|
4.67 |
1 |
| 19. |
Esophageal Squamous Cell Carcinoma
|
|
|
1 gene: NFE2L2
|
4.65 |
1 |
| 20. |
Acute Lung Injury
|
|
|
1 gene: NFE2L2
|
4.58 |
1 |
| 21. |
Endometrial Neoplasms
|
|
|
1 gene: NFE2L2
|
4.57 |
1 |
| 22. |
Endometriosis
|
|
|
1 gene: NR3C1
|
4.57 |
1 |
| 23. |
Non-alcoholic Fatty Liver Disease
|
|
|
1 gene: NFE2L2
|
4.57 |
1 |
| 24. |
Hypokalemia
|
|
|
1 gene: NR3C1
|
4.56 |
1 |
| 25. |
Diabetic Nephropathies
|
|
|
1 gene: NFE2L2
|
4.48 |
1 |
| 26. |
Bipolar Disorder
|
|
|
1 gene: NR3C1
|
4.46 |
1 |
| 27. |
Pulmonary Fibrosis
|
|
|
1 gene: NFE2L2
|
4.38 |
1 |
| 28. |
Schizophrenia
|
|
|
1 gene: NR3C1
|
4.36 |
2 |
| 29. |
Micronuclei, Chromosome-Defective
|
|
|
1 gene: NFE2L2
|
4.31 |
1 |
| 30. |
Skin Neoplasms
|
|
|
1 gene: NFE2L2
|
4.25 |
1 |
| 31. |
Carcinoma, Squamous Cell
|
|
|
1 gene: NFE2L2
|
4.24 |
1 |
| 32. |
Depressive Disorder
|
|
|
1 gene: NR3C1
|
4.21 |
1 |
| 33. |
Hyperglycemia
|
|
|
1 gene: NFE2L2
|
4.19 |
1 |
| 34. |
Neurotoxicity Syndromes
|
|
|
1 gene: NFE2L2
|
4.17 |
1 |
| 35. |
Liver Cirrhosis
|
|
|
1 gene: NFE2L2
|
4.16 |
1 |
| 36. |
Cocaine-Related Disorders
|
|
|
1 gene: NR3C1
|
4.14 |
2 |
| 37. |
Hyperplasia
|
|
|
1 gene: NFE2L2
|
4.14 |
1 |
| 38. |
Dermatitis, Allergic Contact
|
|
|
1 gene: NFE2L2
|
4.11 |
1 |
| 39. |
Cholestasis
|
|
|
1 gene: NFE2L2
|
3.97 |
1 |
| 40. |
Heart Failure
|
|
|
1 gene: NFE2L2
|
3.90 |
1 |
| 41. |
Liver Neoplasms
|
|
|
1 gene: NFE2L2
|
3.89 |
1 |
| 42. |
Carcinoma, Hepatocellular
|
|
|
1 gene: NFE2L2
|
3.85 |
1 |
| 43. |
Acute Kidney Injury
|
|
|
1 gene: NFE2L2
|
3.75 |
1 |
| 44. |
Hypertension
|
|
|
1 gene: NR3C1
|
3.73 |
2 |
| 45. |
Drug-Related Side Effects and Adverse Reactions
|
|
|
1 gene: NFE2L2
|
3.72 |
1 |
| 46. |
Kidney Diseases
|
|
|
1 gene: NFE2L2
|
3.62 |
1 |
| 47. |
Necrosis
|
|
|
1 gene: NFE2L2
|
3.57 |
1 |
| 48. |
Liver Cirrhosis, Experimental
|
|
|
1 gene: NFE2L2
|
3.50 |
1 |
| 49. |
Drug-Induced Liver Injury
|
|
|
1 gene: NFE2L2
|
3.34 |
4 |